Kurt Mevlut, Onal Ibrahim K, Elkiran Tamer, Altun Bulent, Altundag Kadri, Gullu Ibrahim
Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Med Oncol. 2005;22(2):203-6. doi: 10.1385/MO:22:2:203.
We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in light of the pertinent literature.